Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago

Possible Interaction: Acetylcholine and Cannabinoids

Research Papers that Mention the Interaction

Cannabinoids also modulate the actions of vasoactive compounds including acetylcholine , methoxamine, angiotensin II and U46619 (thromboxane mimetic).
British journal of pharmacology  •  2014  |  View Paper
Functional studies have shown that activation of cannabinoid CB(1 ) receptors inhibits the synaptic release of many neurotransmitters such as gamma-aminobutyric acid, glutamate, acetylcholine and monoamines.
European journal of pharmacology  •  2008  |  View Paper
The administration of Delta(9)-tetrahydrocannabinol (Delta(9)-THC) and synthetic cannabinoids stimulates acetylcholine (ACh) release in the rat prefrontal cortex (PFCx) and hippocampus as estimated by brain microdialysis.
Neuropharmacology  •  2006  |  View Paper
Cannabinoids can reduce the pre-synaptic release of acetylcholine and other neurotransmitters in the mammalian brain through a retrograde signaling pathway.
Toxicology  •  2006  |  View Paper
suggesting that acetylcholine output is tonically inhibited by endogenous cannabinoids.
European journal of pharmacology  •  1998  |  View Paper
The results confirm previous observations that cannabinoids inhibit acetylcholine release through cannabinoid CB1 receptors, and indicate that no tolerance to this effects develops after a repeated Delta9-THC administration.
Brain Research  •  1998  |  View Paper
themselves increased hippocampal acetylcholine release, suggesting that acetylcholine output is tonically inhibited by endogenous cannabinoids.
European journal of pharmacology  •  1997  |  View Paper
Accumulating evidence suggests that the cannabinoids exert their action to reduce the turnover rate of acetylcholine in the hippocampus by an action in the septum via inhibitory gamma-butyric acid (GABA) containing interneurons.
Life sciences  •  1982  |  View Paper
Abstract Recent evidence suggests that the cannabinoids exert their action to reduce the turnover rate of acetylcholine in the hippocampus by an action in the septum via inhibitory gamma-butyric acid containing interneurons.
Neuropharmacology  •  1981  |  View Paper